Articles

32 articles
Tag: biotech ✕
Synthetic Biology Market Hits $50 Billion: Engineering Life to Solve Global Challenges Science
2026-04-01T12:15:05.845Z · Src: 2026-04-01T00:00:00.000Z
synthetic biologycrisprginkgo bioworks
Longevity Science Investment Surges as Anti-Aging Treatments Show Clinical Promise Science
2026-04-01T11:52:04.186Z · Src: 2026-04-01T00:00:00.000Z
longevityanti agingbiotech
CRISPR Gene Therapy Enters Mainstream: Three FDA-Approved Treatments Signal New Era Science
2026-04-01T11:41:49.419Z · Src: 2026-04-01T00:00:00.000Z
crisprgene therapyfda
AI Drug Discovery Enters Clinical Reality: First AI-Designed Drugs Show Promise Science
2026-04-01T11:35:48.226Z · Src: 2026-04-01T00:00:00.000Z
aidrug discoverypharmaceuticals
How CRISPR Gene Editing Is Moving From Labs to Hospitals Science
2026-04-01T10:09:44.900Z · Src: 2026-04-01T15:00:00.000Z
crisprgene editingcasgevy
How AI Is Transforming Drug Discovery From 10 Years to 18 Months AI
2026-04-01T09:53:30.236Z · Src: 2026-04-01T15:00:00.000Z
ai drug discoveryinsilicorecursion
A-Shares Midday Report: Medical Stocks Lead Gains, Military and Power Lag Business
2026-04-01T04:31:26.738Z · Src: 2026-04-01T12:00:00.000Z
a shareschinamidday
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion in Rare Disease Expansion Business
2026-03-31T12:54:14.765Z · Src: 2026-03-31T12:00:00.000Z
biogenapellism a
Biogen to Acquire Apellis for $5.6B, Expanding into Immunology and Rare Disease Business
2026-03-31T12:52:55.829Z · Src: 2026-03-31T12:44:00.000Z
biogenapellism a
'Zombie Cells' Resurrected from the Dead With Genome Transplants: Synthetic Biology Breakthrough at J. Craig Venter Institute Science
2026-03-29T19:25:28.762Z · Src: 2026-03-29T00:00:00.000Z
syntheticbiologygenomejcvi
Japan Research Reveals How Coffee Compound Limits Colorectal Cancer Growth Science
2026-03-27T02:16:33.186Z · Src: 2026-03-27T00:00:00.000Z
coffeecancercolorectal
R3 Bio Wants to Grow 'Organ Sacks' — Brainless Organ Systems — to Replace Animal Testing Science
2026-03-24T02:04:47.981Z · Src: 2026-03-23T15:46:00.000Z
R3 Bio, backed by a Singapore longevity fund, is developing brainless 'organ sacks' — complete organ systems without a brain — to replace animal testing as the US government phases out animal experime
biotechanimal testingorgan sacks